Shaping the Future of Early Access in Europe Understanding the Impact of New EU Pharmaceutical Legislation

• Exploring what the new EU pharmaceutical legislation introduces for early and compassionate access pathways
• Understanding the opportunities and challenges this creates for industry regulators and patients across Europe
• Highlighting how stakeholders can collaborate to maximise the impact of the new framework
• Setting the foundation for broader discussion on how early access can evolve under this changing regulatory landscape 

Speakers:

Pedro Franco

Senior Director & Head of Europe Global Regulatory & Scientific Policy,

Merck KGaA

Vilem Guryca

Director, Expanded Access, Global Medical Affairs

BeOne Medicines

Ramona Reichenbach

Managed Access & Medical Policy Head

Novartis AG